SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]:
SEC Accession No. 0001193125-20-136536
Filing Date
2020-05-07
Accepted
2020-05-07 18:52:13
Documents
2
Effectiveness Date
2020-05-07

Document Format Files

Seq Description Document Type Size
1 S-1MEF d893348ds1mef.htm S-1MEF 37359
2 EX-23.1 d893348dex231.htm EX-23.1 2934
  Complete submission text file 0001193125-20-136536.txt   41371
Mailing Address 1313 N. MARKET STREET SUITE 5100 WILMINGTON DE 19801
Business Address 1313 N. MARKET STREET SUITE 5100 WILMINGTON DE 19801 (857) 444-0553
Ayala Pharmaceuticals, Inc. (Filer) CIK: 0001797336 (see all company filings)

IRS No.: 823578375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1MEF | Act: 33 | File No.: 333-238094 | Film No.: 20858154
SIC: 2836 Biological Products, (No Diagnostic Substances)